Cancer control potential of marine natural product scaffolds through inhibition of tumor cell migration and invasion

被引:18
|
作者
Mudit, Mudit [1 ]
El Sayed, Khalid A. [2 ]
机构
[1] DYouville Coll Sch Pharm, Dept Pharmaceut Social & Adm Sci, Buffalo, NY 14201 USA
[2] Univ Louisiana Monroe, Sch Pharm, Dept Basic Pharmaceut Sci, Monroe, LA 71201 USA
关键词
XESTOSPONGIA-EXIGUA KIRKPATRICK; RICH CYCLIC OCTAPEPTIDE; MOTUPORAMINES A-C; BREAST-CANCER; DRUG DISCOVERY; IN-VITRO; PHENYLMETHYLENE HYDANTOINS; MESENCHYMAL TRANSITION; BIOLOGICAL-PROPERTIES; ANTICANCER AGENTS;
D O I
10.1016/j.drudis.2016.06.032
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The marine environment is a reliable source for the discovery of novel treatment options for numerous diseases. Past research efforts toward the discovery of marine-derived anticancer agents have resulted in several commercially available marine-based drugs. The pharmaceutical value of anticancer drugs from marine natural products (MNPs) ranges from US$563 billion to US$5.69 trillion. In this review, we highlight several marine-derived entities with the potential for cancer control and prevention through the inhibition of crucial tumor cell motility and/or migration steps involved in subsequent cancer metastases. This report also covers the major hurdles typically faced by the MNPs research scientific community.
引用
收藏
页码:1745 / 1760
页数:16
相关论文
共 50 条
  • [41] Effects of raloxifene on breast cancer cell migration and invasion through the actin cytoskeleton
    Flamini, Marina Ines
    Fu, Xiao-Dong
    Sanchez, Angel Matias
    Giretti, Maria Silvia
    Garibaldi, Silvia
    Goglia, Lorenzo
    Pisaneschi, Silvia
    Tosi, Veronica
    Genazzani, Andrea Riccardo
    Simoncini, Tommaso
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (8B) : 2396 - 2407
  • [42] The Inhibition of Src Family Kinase Suppresses Pancreatic Cancer Cell Proliferation, Migration, and Invasion
    Je, Dong Wook
    Moon, Young O.
    Ji, Young Geon
    Cho, Yunkyung
    Lee, Dong Hyeon
    PANCREAS, 2014, 43 (05) : 768 - 776
  • [43] Inhibition of cell invasion and migration by CEACAM1-4S in breast cancer
    Yang, Changcheng
    Cao, Manlin
    Liu, Yiwen
    He, Yiqing
    Yang, Cuixia
    Du, Yan
    Wang, Wenjuan
    Zhang, Guoliang
    Wu, Man
    Zhou, Muqing
    Gao, Feng
    ONCOLOGY LETTERS, 2017, 14 (04) : 4758 - 4766
  • [44] Control of tumor cell migration and invasion by Rac1 and Rac3
    Chan, AY
    Coniglio, SJ
    Chuang, Y
    Symons, M
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 43A - 43A
  • [45] Curcumin Can Inhibit The Invasion, Migration And Angiogenesis Of Non-Small Cell Lung Cancer Through Inhibition Of β-Catenin Expression
    Chong, I. -W.
    Tsai, J. -R.
    Liu, P. -L.
    Wang, T. -H.
    Hwang, J. -J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [46] KLF2 transcription suppresses endometrial cancer cell proliferation, invasion, and migration through the inhibition of NPM1
    Cheng, Xiyun
    Shen, Changmei
    Liao, Zhenrong
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2023, 43 (02)
  • [47] ARHGAP30 suppressed lung cancer cell proliferation, migration, and invasion through inhibition of the Wnt/β-catenin signaling pathway
    Mao, Xiaoliang
    Tong, Jichun
    ONCOTARGETS AND THERAPY, 2018, 11 : 7447 - 7457
  • [48] miR-623 suppresses cell proliferation, migration and invasion through direct inhibition of XRCC5 in breast cancer
    Li, Qing
    Liu, Jiangtao
    Jia, Yanli
    Li, Tingting
    Zhang, Mei
    AGING-US, 2020, 12 (11): : 10246 - 10258
  • [49] α-Lipoic acid inhibits the migration and invasion of breast cancer cells through inhibition of TGFβ signaling
    Tripathy, Joytirmay
    Tripathy, Anindita
    Thangaraju, Muthusamy
    Suar, Mrutyunjay
    Elangovan, Selvakumar
    LIFE SCIENCES, 2018, 207 : 15 - 22
  • [50] Vinculin orchestrates prostate cancer progression by regulating tumor cell invasion, migration, and proliferation
    Zheng, Xiaonan
    Xu, Hang
    Gong, Lina
    Cao, Dehong
    Jin, Tao
    Wang, Yan
    Pi, Jinkui
    Yang, Yang
    Yi, Xianyanling
    Liao, Dazhou
    Jin, Xi
    Wei, Qiang
    Yang, Lu
    Li, Hong
    Ai, Jianzhong
    PROSTATE, 2021, 81 (06): : 347 - 356